Dr Fei Deng
Research Associate

Dr Fei Deng

Engineering
Grad Sch: Biomedical Eng

Dr Deng is currently a research associate in Graduate School of Biomedical Engineering, UNSW. Dr Deng obtained his Master of Engineering in Chemical Engineering from Korea University of Technology and Education (2016, Republic of Korea). He received his Ph.D. degree (specialising in point-of-care biosensing and Biomedical Engineering, 2021) from The University of New South Wales (UNSW), Sydney, NSW, Australia. He subsequently took up a postdoctoral research fellowship at the Graduate School of Biomedical Engineering (GSBmE), UNSW. Deng’s research interests include point-of-care biosensing device, continuous biosensing device, CRISPR biosensing device and in vivo biosensing device. He is currently a key member of a multi-disciplinary team in GSBmE, leading the development of point-of-care biosensing device and real time continuous biosensing device.

 

Editorial Activities:

  • Associate Editor for Diagnostic and Therapeutic Devices, Frontiers in Medical Technology.
  • Topic Editor – Frontiers in Medical Technology, Diagnostic and Therapeutic Devices, Research Topic “Photonic Biosensors for Biomedical Applications and Environmental Monitoring”.

Leading experience

  • The host of Bio-focus seminar (2022), CNBP Node at Graduate School of Biomedical Engineering. 

 

Phone
0451876009
  • Journal articles | 2022
    Li Y; Deng F; Goldys EM, 2022, 'A simple and versatile CRISPR/Cas12a-based immunosensing platform: Towards attomolar level sensitivity for small protein diagnostics', Talanta, vol. 246, pp. 123469, http://dx.doi.org/10.1016/j.talanta.2022.123469

  • Diversity in Engineering Academic Visitors Funding from UNSW ($5K) in 2022, sole-CI. 
  • 3Rs Grant from UNSW ($50K) in 2022, co-CI.
  • MERCK competitive research award (Euro 450,000) in 2022-2024, co-CI.
  • Two Innovation connections grants ($50K each) in 2021 (RG211246, RG210091), which is on ultrasensitive detection of cryptosporidium using CRISPR/Cas technology, co-CI on both.
  • One EDI and ECAN seed funding from UNSW ($1k) in 2021, sole-CI.

  1. Australian Centre for NanoMedicine (ACN) Travel Award (2022)
  2. PhD Scholarship in Sandwich assay based deployable biosensors (2017-2021)
  3. Excellent Graduate Thesis (Master, 2016)
  4. Foreigners Scholarship (Master, 2013-2016)
  5. Secondary Prize of Tianjin chemistry competition (Bachelor, 2011)

Patent

  1. CRISPR/Cas-associated detection assays, methods and kits. (2021) PCT Patent. International application No. PCT/AU2022/050829.  
  2. Biosensor. (2022) Australian provisional patent No. P0046904AU
  3. Ultrasensitive CRISPR biosensors assisted by circular mediators. (2022) Australian provisional patent No. P0048952AU

 

My Research Supervision

Supervision Experience

  1. Co-supervised PhD research project: Capture and detection of waterborne parasites using existing and emergent technologies (T. Hall)
  2. Co-supervised PhD research project: Programmable nucleases and applications in biosensing (X. Zhai)
  3. Co-supervised PhD research project: Novel biosensors for exosome detection (P. Mohammadnejad)